Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects

Research output: Contribution to journalJournal articleResearchpeer-review

  • W Philip T James
  • Ian D Caterson
  • Walmir Coutinho
  • Nick Finer
  • Luc F Van Gaal
  • Aldo P Maggioni
  • Torp-Pedersen, Christian Tobias
  • Arya M Sharma
  • Gillian M Shepherd
  • Richard A Rode
  • Cheryl L Renz
  • SCOUT Investigators
  • Maria Helena Dominguez Vall-Lamora
  • Perrild, Hans
The long-term effects of sibutramine treatment on the rates of cardiovascular events and cardiovascular death among subjects at high cardiovascular risk have not been established.
Original languageEnglish
JournalNew England Journal of Medicine
Volume363
Issue number10
Pages (from-to)905-17
Number of pages13
ISSN0028-4793
DOIs
Publication statusPublished - 2 Sep 2010

    Research areas

  • Aged, Appetite Depressants, Blood Pressure, Cardiovascular Diseases, Cyclobutanes, Diabetes Mellitus, Type 2, Double-Blind Method, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Infarction, Obesity, Overweight, Stroke

ID: 32478699